EQUITY RESEARCH MEMO
Levita Magnetics
Generated 5/11/2026
Executive Summary
Conviction (model self-assessment)65/100
Levita Magnetics is a Silicon Valley-based medical device company pioneering Magnetic Surgery® and AI-guided autonomous surgical platforms. Founded in 2012, the company has developed the MARS® platform, which integrates magnetic technology and artificial intelligence to enhance precision and efficiency in minimally invasive surgery. The platform aims to improve patient outcomes and streamline surgical workflows, with a landmark case in Chile demonstrating its application in gallbladder surgery. Levita's technology addresses key limitations of conventional laparoscopic surgery, such as instrument clashing and limited visualization, by enabling fewer incisions and greater dexterity.
Upcoming Catalysts (preview)
- Q4 2026FDA 510(k) clearance for MARS platform expanded indications60% success
- Q2 2027Publication of clinical study results in bariatric surgery50% success
- Q3 2026Strategic partnership with major surgical robotics company40% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)